Name: Walid M. El-Habashy

Current Position: Marketing manager in Pfizer Egypt

Telephone contact: Mobile: 010******** Home :02 26206136

E .mail: www.linkedin.com/in/walid-el-habashy-9267b5b

elhabashywalid @gmail.com

elhabashywalid @yahoo.com

Personal Details

Date of Birth: 24.1.1965

Nationality: Egyptian

Car Availability: Yes (available)

Marital status / kids: Married

Address: 12 Al Nawary Street, Heliopolis, Cairo

Education and Qualification

-Bachelor degree in pharmaceutical Science (1986)

-Diploma in Marketing from Cambridge College

Computer Skills:

Microsoft Excel, Word, PowerPoint

Work Experience

HYPERLINK "https://www.linkedin.com/company/5166663/"

In 2019 - till now business unit manager for Atos pharma

From may 2017 till sep.2018-Marketing Manager in Pfizer Egypt with 62 $ sales contributio

From Jan.2013 tilll May 2017 Country portfolio lead for the Anti –infective and outsourcing Portfolio

From july 2010 till Jan.2013 Marketing manager for Gynato-urinary portofolio

My Responsibility:

Successfully launch Path forward project in Egypt and to Restore 80% of Pfizer revenue with 50% of the field force

Get the Market, Customer and Competitor Insight: as I could generate actionable insights and find new opportunities through a high level of understanding for our markets, customers, end-users/consumers, competitors, and the changing environment.

Marketing Execution: I had the ability to develop and implement communication platforms with the needed marketing tactics to support the brand strategy,

Strategic and Operational Business/Marketing Planning: I lead my team in the execution of the strategic direction for our brands, portfolio, region, or therapeutic area, in alignment with company and goals and plans.

Title: Country portfolio lead for the Anti –infective and outsourcing Portfolio

Dates: From January 2013 until May 2017

My Responsibility:

Data Analysis, Interpretation, and Communication: I was able to analyze the data generated from IMS & CLM to identify the key market opportunities

Performance and Program Metrics: I measures and evaluates the impact of our key activities and programs.

Forecasting : initiate our long term sales revenue and develop the relevant strategy and tactics for upcoming 5-10 years

Challenging: Our sales team by setting their sales and expense budget and discuss our brand strategies and Tactics

Endorsement: of the whole stakeholder to ensure our high performance and develop our product mix, and Average sales price with our key account customers

Marketing Execution :And the ability to create and shift the gear to achieve our corporate goals

Title: Marketing Manager for the Gento -urinary business units

Dates: From July 2010 until Jan 2013

My Responsibility:

In 2011 the Gento -urinary business units achieves 33% growth over 2010 ( Unasyn oral 42% growth,Unasyn injection 37% growth, Dostinex 21% growth,and Diflucan 27% growth

Marketing Execution: I had the ability to develop and implement communication platforms with the needed marketing tactics to support the brand strategy,

Strategic and Operational Business/Marketing Planning: I lead my team in the execution of the strategic direction for our brands, portfolio, region, or therapeutic area, in alignment with company and goals and plans.

Previous Work Experience

From

To

Company

Position

Location /therapy area

1997

2000

Pharmacia&

Upjohn

Product manager &Clinical research associate (CRA)

Ophthalmology, endocrinology and urology as (CRA)

2000

2002

Pharmacia

Product Champion MENeA

Endocrinology and ophthalmology

2002

2003

Pharmacia

Group Product Manger

Egypt (Ophthalmic and endocrinology)

2003

2008

Pfizer

Product Manger

Egypt,Gulf and Levant (Ophthalmic,endocrinology and critical care)

2009

2011

Pfizer

Senior Product manager

Egypt (Ant infective and Prolactin inhibitor)

HISTORY OF ACCOMPLISHMENTS TASK

1.I was recognized as best PSR in Pharmacia in terms of Performance and sales then I was promoted as Senior Product specialists in Cardiovascular and total parental nutrition in 1993

2.In 1996,I was promoted as a Product Manager for ophthalmology and endocrinology

3.In 1997, I was able to launch Genotropine for endocrinologists and to make Genotropine as the drug of choice for short stature chidren and to secure its leading position among growth hormone deficiency segment in Saudi arabia and the Gulf markets.

4.In 1998,I was selected to conduct a clinical trial for Detrusitol as a prelaunch activity in three big accounts and the numbers of patients included were 60 patients and the impact of this trial was highly relevant on Detrusitol registration

5.In 2002,I was able to launch Xalatan as an innovative treatment in Glaucoma treatment in Saudi Arabia and United Arab of Emirate, I was be to get Number 1 rank (IMS DATA, 2002) within two years after the Launch.

6.In 2003,I was promoted as a group product manager for Egypt and I was responsible for ophthalmology,endocrinology and critical care in AFME and to generate almost 43 M$ from these therapy area.

7.In 2009, I was assigned as senior product manager for Anti- infective and Prolactin inhibitor in Egypt and I was able achieve 96 MLE with 16% growth (Unasyn 12% growth, Dostinex 41% growth and Diflucan 16% growth)

8.In 2011, I was assigned as Marketing manager and I was able to achieve with the GU team 89 MLE ( with 30% growth in Dostinex and 9% growth in Diflucan)

9.In 2012, The GU Team achieve 119 MLE with 33% growth over last year ( Unasyn oral 42% growth,Unasyn injection 37% growth, Dostinex 21% growth,and Diflucan 27% growth)

10.In 2013, I moved to the outsourced team and we succeed to achieve 63.5 M LE and these sales revenue were driven by Feldene flash 21% growth,Ponstan 25% growth and Debridat 21% growth as we were able to build up the team and effectively manage their Target, Training,development, mentor their IDP and finally assess their performance

11.In 2014, the outsourcing products achieve 55 MLE with 11% growth ( Feldene amp. achieve 14 MLE with 9% while Feldene oral achieve 15 MLE with 7% growth) and we were able to switch Multi pharm outsourced products to UCP without compromising the sales revenue.

12.In 2015,I work closely with Pfizer and UCP management to deliver the challenging financial outcomes that are needed to achieve Pfizer and UCP sales Objectives and to achieve 60 MLE (YTD P10,2015 sales 46.5 MLE that 99% Vs target with 9% growth)

13.In 2017, I get new responsibility as marketing manager to lead Pfizer Anti –infective that represent 758 MLE sales revenue with 58% share and my team composed of three Product Manager responsible for Pfizer Anti-bacterial and Anti-Fungal portfolio

14.In 2017, I shared in the Portfolio optimization project that has the responsibility to assign the new team structure (Hospital and Private ) and the portfolio under their responsibility

15.In 2017, I was a member of the CM forum that will conduct the path forward project (Restore 80% of Pfizer revenue with 50% of the field force)

16.In 2018 we Successfully conduct the critical care Summit, I care summit and 57357 preceptorship Symposium with almost 180 oncologists from AfMEA region

17.In 2018,we were able to Launch Meronem and Precedex in Egypt

18.In 2018 Pfizer Egypt Anti-infective was selected among the top 20 top performer markets worldwide as we were able to be ranked as No1 Anti-infective company among the Egyptians Pharmaceutical companies in Hospital sector

My professional development

Diploma in Marketing from Cambridge college

Sales management (1991-1993)

Marketing management (1991-1993)

Strategic business planning 1st part (London 1996)

Strategic business planning 2nd part (Paris 1997)

Clinical research associate program (Italy1997)

Strategic operating procedure ( Italy1997)

Pharmacia Marketing model program ( Barcelona 2001)

Strategic brand management (Milan 2001)

Best managed Behavior &Leadership skills (Dubai 2002)

Advanced product manager development (Paris,2005)

Strategic planning, market analysis, forecasting and advertising (livon,Cairo,2006)

Strategic thinking (Cairo,2008)

Market research (Burke institute) December.2012

Corner stone of Management 2A (Dubai) 2013

Corner stone of Management 2B(Cairo) 2013

My learning transcript through Pfizer skill soft

My learning transcript

Title

date of completion

Score

Principles of Accounting and Finance for Non-financial Professionals

8-Sep-17

78

Developing the Capacity to Think Strategically

25-Aug-17

86

Developing Character for Decisiveness

24-Aug-17

78

Final Exam: Developing Strategic Thinking Acumen

20-Aug-16

75

Decision Making: The Fundamentals

2-Aug-15

87

Surpassing the Competition

7-Apr-15

87

Marketing Management

29-Sep-14

80

Conflict, Stress, and Time Management

22-Sep-14

73

Customer-driven Process Improvement: Identifying Customer Needs

17-Sep-14

92

Thinking Strategically

15-May-11

99

Business Coaching: Building the Coaching Relationship

28-Sep-11

87

Six Sigma Leadership and Change Management

5-May-11

84

Operations Management: Product and Service Management

5-Jul-11

87

Business Coaching: Using Different Coaching Styles

28-Sep-11

87

Leadership Development for Technical Professionals

21-Mar-11

96

Dynamics of Leadership

17-Mar-11

87

My area of responsibility

1) Products sales revenue

1.Managing the products P&L and tailoring the marketing plans to optimize the product line margin

2.Give the sales manager and medical representative the guidance for the proper approach for the key target customers

3.To share the sales manager forecast for the upcoming sales and the proper distribution for the sales target among the different products

4.Managing the commercial plans for the key products in the outsourcing portfolio

5.Advising UCP top management regarding the proper commercial plans for the whole year

6.Sharing UCP the best deals to manage Pfizer portfolio in the different UCP warehouses to achieve their sales target

7.Set the templates needed for sales manager and the sales representative to represent their achievement in front of the higher management

8.To reach for a common agreement regarding the number of calls, frequency and the target specialty that will be covered during the coming period

9.To cascade the agreed prepositioning statement for the products among the selected target specialty

10.To generate materials that will help in improving the implication of untreated patients and the benefits the patients will get from the treatment

11.Monitor sales results & expenses on monthly basis and to locate the needed resources for the planned activities

12.Provide accurate forecasting for the assigned products in term of budgeting & inventory for the higher management in Pfizer to manage the production plan with Pfizer factory

2) Market Plan

1.Analyze the market trends to identify the potential area that we have to tackle for the product under my responsibility

2.Prepare realistic & achievable objectives, strategies & tactics for assigned products on the different governorate

3.To submit the market tactical matrix in the U Qube system to get the regional approval to the agreed activity

4.Ensure the proper execution for the strategic and tactics as agreed in the product plan.

5.Consistent communication with sales forces to understand the market growth drivers.

6.To secure the regional team support for the local planed activity (pain academy meetings)

7.To set an consolidated plan for the Anti bacterial and Anti fugal portfolio

3) Promotional campaigns

1.Assist the Product manager to develop the promotional campaigns that was incorporated in the product plan

2.Communicate and secure the required promotional material in reasonable time

3.Secure the medical support needed for the team (AV activity, clinical trial)

4.Ensure that the delivered message are serving the agreed strategy

5.Review the team action plans for the upcoming period

6.Monitor & evaluate promotional campaigns on regular basis.

4) Product development

1.To accelerate the new products registration with the regulatory Dep. to optimize our portfolio performance

2.To co-ordinate and lead projects that will meet the untapped potential in the market and turn it to profitable segment (Pain academy meeting)

3.To develop an alternative plans to recap AI sales growth especially with Tier 1,2,3 portfolio

5) Challenging Task:

1.Product specialist for total parental nutrition and cardiology

2.Implement two clinical trial (Intraocular lenses and Detrusitol)

3.Successful Launch for Xalatan and Xalacin in Saudi Arabia and Gulf

4.Working as Product Champion for ophthalmology,critical care and endocrinology (Middle East,north East Africa)

5.Revitalize Sou-Medrol sales revenue in Egypt and Levant

6.To boost Pfizer image in anti-infective especially with Unasyn oral and Injection

7.To be market leader in prolactin inhibitor with Dostinex

8.Renewal the outsourcing contract with Pfizer and UCP

9.To manage the outsourcing portfolio

10.To conduct the path forward project

11.Portfolio optimization project (Tiers 1,2,3,4 and Negative)

6) My Competence:

1- Talented to identify market opportunities and turn them into profitable segment

2- Capable to manage the different level in the commercial team (Professional sales rep.,

Sales manager, UCP sales department)

3- Skillful to prepare a realistic and achievable objectives, strategies and tactics on Country level

& Area Level

4- Good communication skills with the other departments to facilitate the execution of the

Agreed Plans (Distributor, Regulatory, HR, Training, legal and the medical dep.)

5- Excellent evaluator and monitor for the different market programs in term of spending

And the expected impact

6-I will optimize the sales performance for the operational and outsourcing portfolio

7- Capable to ensure the high Quality execution for the plans and the pre –set projects

8- Seeking for new ways to get the task done and open for new ideas to achieve the sales target

9-Acts decisively by taking decision that will positively impact on our outsourcing business in

Future

10-Seizes Accountability by taking the charge to start the actions that will get the job done

11- Change Agile was a great challenge when the outsourcing business were not going well

(Multi Pharm branch) and we decide to exclude them and move to UCP

12-I succeed to work closely with the Country leadership team to provide the needed data for

Operating plan for 2018 and the long range forecast until 2023

13-Launch Plan for new Ant infective products Zinforo and Zavicefta

REFERENCES:

Yousri Nawar : Egypt and Sudan country lead adg05x@r.postjobfree.com

Contact this candidate